New River Pharma (Nasdaq: NRPH) Update

New River Pharma (Nasdaq: NRPH) filed an application for a pediatric ADHD drug. The stock saw a nice afternoon pop. I mentioned this stock on Monday as a speculative stock play.

Briefing News
Press Release

Note: I am long NRPH